TN loses 50 MBBS seats for '25 admission
On Friday, the seat matrix showed permission was granted for the admission of 1.15 lakh students in 766 colleges in India. This includes 12,000 seats in 77 colleges –– AIIMS-Madurai, ESIC, govt and private colleges –– in Tamil Nadu. While there were no changes in the number of seats in 76 medical colleges, PSP Medical College and Research Institute in Kancheepuram, which had permission to admit 150 MBBS candidates in 2024, was granted permission to appoint only 100 students this year.
The selection committee in the Directorate of Medical Education, in charge of admissions in Tamil Nadu, said admissions will be done for the seats approved by the council. "Seats that are not approved will be removed from the seat matrix by the TN Dr MGR Medical University," a senior official said.
You Can Also Check:
Chennai AQI
|
Weather in Chennai
|
Bank Holidays in Chennai
|
Public Holidays in Chennai
Seats in at least nine colleges – one each in AP, Chhattisgarh, Delhi, Gujarat, Karnataka, Madhya Pradesh, Rajasthan, Telangana, and UP – were brought down to zero.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Assam set to emerge as hub for medical education and health tourism: CM Sarma
Assam Chief Minister Himanta Biswa Sarma Assam is expected to have over 60 medical colleges - both public and private - by 2035. The project, to be developed over 74 bighas at an estimated cost of Rs. 357 crores would comprise accommodation for the Vice-Principal, Medical Superintendent, faculty members, and third- and fourth-year students, including those pursuing MBBS, postgraduate, and GNM courses. This initiative forms part of a broader infrastructural enhancement plan approved by the State Cabinet on 18 July. Explore courses from Top Institutes in Please select course: Select a Course Category Finance Leadership others PGDM Technology Design Thinking CXO MBA Degree Data Analytics Healthcare Public Policy Project Management Management Artificial Intelligence Product Management Cybersecurity Digital Marketing Others Data Science Data Science MCA Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Sarma recalled that during 2006–07, Assam faced an acute shortage of medical professionals. However, he noted that the establishment of new medical colleges since 2011 has significantly bridged this gap. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 32 Most Beautiful Women In The World Undo He stated that by 2035, the state is expected to have 30 functional government medical colleges. In addition, applications from private entities have been received, though permission for such institutions would be granted only after the proposed government colleges become operational. As a result, Assam is expected to have over 60 medical colleges - both public and private - by 2035. Highlighting recent developments, the Chief Minister stated that 500 doctors have already been appointed to the health department this year. He said that, by 2030, medical colleges in the state should be producing at least 1,500 MBBS graduates annually, which would also alleviate the shortage of postgraduate-qualified doctors. With enhanced infrastructure and academic facilities, Assam is poised to be recognised as a state with a competent medical workforce by 2035 and is likely to emerge as a centre for both medical education and health tourism. Live Events He mentioned that private players have expressed interest in healthcare ventures in Assam: the Medanta Group has proposed a 1,000-bed nursing home with a five-star hotel in Guwahati, while the Ambuja Neotia Group has plans to develop a 500-bed hospital and a luxury hotel in Borjhar. He expressed confidence that the state could become a global supplier of medical professionals. Sarma informed that the state government has begun offering foreign language training to nursing students and other professionals. He remarked that nurses employed abroad - such as in Japan and Singapore - are earning between Rs. 1 lakh and Rs. 2.5 lakh per month, and that discussions are underway with the United Arab Emirates for similar opportunities. He added that medical graduates and postgraduates from Assam may also be able to access international employment opportunities, provided educational standards are consistently upheld. Citing global interest following the Advantage Assam 2.0 summit, he stated that Japan and South Korea have expressed intent to collaborate with Assam in the medical sector. He further observed that while Assam's infant and maternal mortality rates are currently lower than the national average, sustained efforts are still required to ensure improved quality of healthcare delivery. The Chief Minister urged Assam Medical College & Hospital to keep pace with contemporary trends and evolve into a premier institution for quality medical education. He acknowledged the historic role of the institution as the sole provider of medical education in Upper Assam but noted that recent establishments in Jorhat and Tinsukia, and ongoing construction in Sivasagar, Charaideo, and Golaghat, would help redistribute the patient load. Consequently, he suggested that the college reorient itself as a specialised referral hospital focusing on critical care. Sarma also referred to the assurance he made during the college's Platinum Jubilee celebrations in November 2022 to build residential facilities for faculty, staff, and students. The current foundation-laying marks the first phase of that commitment, covering one-third of the total housing requirement. The subsequent phases would cater to the remaining housing needs, including those of the dental and BSc nursing colleges, with an estimated outlay of Rs. 1,000 crores. He also mentioned that work has commenced on the CT Hospital wing. Furthermore, he expressed hope that the institution, which currently offers 200 MBBS seats, would receive approval for an additional 50 seats in the present academic year.
The Hindu
3 hours ago
- The Hindu
All you need to know about: sarcoidosis
Sarcoidosis is an inflammatory condition that can affect several organs. A disease of unknown etiology or chronic inflammation can lead to permanent scarring of the affected tissues. Considered a rare disease, research is ongoing to understand further the causes, diagnosis and treatment modalities. What is sarcoidosis? Sarcoidosis is believed to be an exaggerated response of the immune system either due to a genetic disposition or due to environmental triggers. It results in affected people developing lumps on their skin or in other parts of the body. The Mayo Clinic website describes the lumps or clusters of immunity cells in an organ as 'tiny collections of immune system cells in any part of the body,' which are red, swollen lumps called granulomas. They commonly occur in lungs and the lymph nodes of the chest, the website adds. What are the symptoms? Persons with sarcoidosis may suffer from a variety of symptoms including fatigue, shortness of breath, wheezing, chronic cough, skin rashes that appear scaly, red eyes, irregular heart beat, weakness or numbness of a limb or part of face, discolouration of the nose, cheek, lips or ears; and chest pain. Some people may remain symptom free as the disease disappears on its own but in some others, though the disease may not progress they may have symptoms that affect their lifestyle. A third of those diagnosed with the condition may require long-term treatment. A person in whom the disease has been active for over two to five years is termed to have a chronic ailment. In such persons, it can be life-threatening. How rare is the condition? In the United States of America an estimated 1.5 to 2 lakh persons live with sarcoidosis. The National Library of Medicine, operated by the United States government, states that the incidence of sarcoidosis is 11 in 1 lakh among the white population and 34 in 1 lakh among the African American population. Across the world an estimated 1.2 million have the condition. In a letter published in 2019 in the Sarcoidosis, Vasculitis and Diffuse Lung Diseases journal, researchers from the All India Institute of Medical Sciences, New Delhi, stated that while the reported prevalence of sarcoidosis in India was estimated to be 10-12 cases per 1,000 new registrations in a respiratory unit at Kolkata and 61.2/100,000 new cases at a centre in New Delhi, 'these figures are unlikely to be a true representation as sarcoidosis is usually unidentified due to the high burden of tuberculosis here. Real figures are anticipated to be much higher.' At AIIMS, Delhi, approximately 100 new cases of pulmonary sarcoidosis are being diagnosed every year, says Rashi Jain, of the department of pulmonary medicine and sleep disorders at AIIMS, Delhi and the main author of the letter. 'The number is quite noticeable for a disease otherwise considered rare,' the letter noted. Organisations working to raise awareness about the disease say approximately five to 10% of all those diagnosed will have advanced sarcoidosis. What are the treatment modalities? Research studies and patient advocate organisations have all called for more research on sarcoidosis to develop effective treatment strategies. Dr. Jain says low awareness about sarcoidosis in India results in doctors misdiagnosing it as tuberculosis. Stating that the condition could cause mental stress due to the multiple evaluations and tests required, she called for exclusive clinics with a multidisciplinary teams of healthcare workers from various specialties, to treat patients with sarcoidosis. Among the affected, around 25% to 30% develop extrapulmonary sarcoid. While in men the heart function is commonly affected, in women, the skin and eyes are more prominently affected. Many persons with the disease recover completely. In those with advanced sarcoidosis (active disease for over two to five years), treatment options include corticosteroids besides other therapies. Persons who require treatment even if they do not have symptoms are also classified as having advanced sarcoidosis. Persons on advanced treatment also need to contend with fatigue, pain, cognitive failure, neuropathy, an inability to exercise and depression besides other comorbidities such as diabetes and high blood pressure.
Mint
3 hours ago
- Mint
Centre plans to introduce $10,000 fee to recognize foreign medical courses
New Delhi: India's National Medical Commission (NMC), the country's apex medical education regulator, has proposed to overhaul rules and introduce a fee to recognize medical courses offered by universities abroad. Under its new draft rules, foreign universities or accreditation agencies will need to pay the NMC a fee of $10,000 ( ₹ 8.6 lakh) for each application seeking recognition by India of a medical course conducted by them. 'Any foreign authority in any country outside India, entrusted with the recognition shall remit $10,000 (US dollars ten thousand only) per qualification as fees to the Commission while submitting its application in a proforma,' the NMC said in a draft notification, amending a clause of the National Medical Commission (Recognition of Medical Qualification) regulations. The development is significant given that 25,000 Indian students go abroad annually to pursue a medical degree, with the preferred countries being Russia, China, Georgia and Kyrgyzstan. These graduate doctors can practise in India only if the NMC recognizes their medical degree. Charging fees for recognition of foreign medical courses is common globally, including in the US, Canada and the UK. Given the limited number of 1.1 lakh MBBS seats in India, and about 2.5 million applicants vying for them, overseas medical education becomes the second choice for many. 'The NMC is doing this to ensure high medical standards in India. The fee helps in formalizing and streamlining the recognition process and ensuring only top-quality foreign qualifications are recognized,' an official familiar with the matter said. 'This amendment particularly impacts the 20,000-25,000 Indian students who study MBBS abroad annually.' The cost of studying medicine in Russia, China, Georgia and Kyrgyzstan ranges from ₹ 18 lakh to ₹ 48 lakh, depending on the course duration (5-6 years), university, city, and living expenses. International bodies such as the World Federation for Medical Education charge about $60,000 to recognize national accrediting agencies. The Educational Commission for Foreign Medical Graduates in the US charges various fees to certify international medical graduates. Mint reported earlier that the government recently appointed a chairman and other key members to fill vacancies in four NMC boards that oversee the functioning of medical colleges in India. Queries sent to the health ministry spokesperson remained unanswered till press time.
